Collaboration Details

Print  Close


Title of Collaborative Activity:

Blood Products Advisory Committee

Description of Collaborative Activity:

The Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases, and, as required, any other product for which the Food and Drug Administration has regulatory responsibility. The committee also advises the Commissioner of Food and Drugs of its findings.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2011

NIH Participating Institutes/Centers/Office of the Director:

NHLBI

HHS Agency Collaborators on this Activity:

CDC, FDA